Kaveri

Ginkgo biloba extract, the active ingredient in Kaveri, is a herbal presented as an oral extract for oral use. It is commonly employed to support cognitive function and peripheral circulation in adults.\n\nGNH India supplies Kaveri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaveri (Ginkgo biloba extract) is used primarily in conditions related to vascular and neurological function.\n\n- Cognitive decline: may help improve memory and attention in age‑related cognitive impairment.\n- Intermittent claudication: supports peripheral blood flow to reduce leg pain during walking.\n- Tinnitus: may alleviate ringing in the ears associated with vascular causes.

Adverse reactions to Ginkgo biloba extract are generally mild but can vary.\n\nCommon Side Effects:\n- Headache: mild to moderate pain often resolves with continued use.\n- Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea.\n- Dizziness: transient light‑headedness, especially on standing.\n- Skin rash: mild allergic dermatitis at the site of contact.\n\nSerious or Rare Side Effects:\n- Bleeding complications: increased risk of hemorrhage, especially with anticoagulants.\n- Severe allergic reaction: anaphylaxis or angioedema requiring emergency care.\n- Liver enzyme elevation: rare hepatotoxicity indicated by raised ALT/AST.\n- Cardiac arrhythmia: uncommon reports of irregular heart rhythm.

When using Kaveri, consider the following safety measures.\n\n- Assess bleeding risk: avoid concurrent use with anticoagulant or antiplatelet therapy unless supervised.\n- Monitor liver function: discontinue if hepatic enzymes become elevated.\n- Avoid in pregnancy: insufficient data; use only if clearly needed.\n- Do not exceed recommended dose: follow prescriber guidance to minimize adverse effects.\n- Store at ambient temperature: keep in the original pack, protect from moisture and light.

Ginkgo biloba extract can interact with several medication classes.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): may increase bleeding risk.\n- Antiplatelet agents (e.g., aspirin, clopidogrel): additive antithrombotic effect.\n- Selective serotonin reuptake inhibitors (SSRIs): potential for enhanced bleeding.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): may potentiate gastrointestinal bleeding.\n\nModerate Interactions (Monitor Closely):\n- Antihypertensive drugs: possible additive blood‑pressure lowering effect.\n- Diabetes medications: may affect glycemic control.\n- Oral contraceptives: potential alteration of hormone levels.